Moderna authorized to test vaccines to fight Ebola virus in Congo

• 58 minutes ago
• News
• Duration 0:35

Health Canada has authorized Moderna to launch a clinical trial for a vaccine targeting the Bundibugyo form of the Ebola virus, which continues to surge throughout the Democratic Republic of the Congo, with more than 1,700 known deaths and 3,800 infections recorded since May. The announcement makes Canada just the second country to launch a Phase 1 clinical trial for a Bundibugyo vaccine candidate after the U.K.